Spliceosome mutations are common in persons with myeloproliferative neoplasm-associated myelofibrosis with RBC-transfusion-dependence and correlate with response to pomalidomide - Chowdhury, O; O’Sullivan, J; Barkas, N; Wang, G; Buck, G; Hamblin, A (Springer Nature, 2020)